4.6 Article

Underappreciated Roles of the Translocase of the Outer and Inner Mitochondrial Membrane Protein Complexes in Human Disease

Journal

DNA AND CELL BIOLOGY
Volume 38, Issue 1, Pages 23-40

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/dna.2018.4292

Keywords

TOMM; TIMM; mitochondrial protein import; disease; genetics; gene and protein expression

Funding

  1. National Research Foundation of South Africa [106052]
  2. South African Medical Research Council (Self-Initiated Research Grant)
  3. Stellenbosch University Faculty of Medicine and Health Science Postdoctoral Fellowship
  4. PROMOS scholarship by the mobility program of the Deutscher Akademischer Austauschienst (DAAD)
  5. International Office of the Humboldt-Universitat zu Berlin

Ask authors/readers for more resources

Mitochondria are critical for cellular survival, and for their proper functioning, translocation of similar to 1500 proteins across the mitochondrial membranes is required. The translocase of the outer (TOMM) and inner mitochondrial membrane (TIMM) complexes are major components of this translocation machinery. Through specific processes, preproteins and other molecules are imported, translocated, and directed to specific mitochondrial compartments for their function. In this study, we review the association of subunits of these complexes with human disease. Pathogenic mutations have been identified in the TIMM8A (DDP) and DNAJC19 (TIMM14) genes and are linked to Mohr-Tranebj AE rg syndrome and dilated cardiomyopathy syndrome (with and without ataxia), respectively. Polymorphisms in TOMM40 have been associated with Alzheimer's disease, frontotemporal lobar degeneration, Parkinson's disease with dementia, dementia with Lewy bodies, nonpathological cognitive aging, and various cardiovascular-related traits. Furthermore, reduced protein expression levels of several complex subunits have been associated with Parkinson's disease, Meniere's disease, and cardiovascular disorders. However, increased mRNA and protein levels of complex subunits are found in cancers. This review highlights the importance of the mitochondrial import machinery in human disease and stresses the need for further studies. Ultimately, this knowledge may prove to be critical for the development of therapeutic modalities for these conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Clinical Neurology

The South African Parkinson's Disease Study Collection

Zune Jansen van Rensburg, Shameemah Abrahams, Devina Chetty, Kathryn Step, Debbie Acker, Carl J. Lombard, Alexis Elbaz, Jonathan Carr, Soraya Bardien

Summary: The incidence of Parkinson's disease is increasing in sub-Saharan Africa, with more Afrikaner Europeans having early-onset PD. More men have PD than women, with men having a younger age at onset (56 years).

MOVEMENT DISORDERS (2022)

Article Genetics & Heredity

Current Status of Next-Generation Sequencing Approaches for Candidate Gene Discovery in Familial Parkinson′s Disease

Nikita Simone Pillay, Owen A. Ross, Alan Christoffels, Soraya Bardien

Summary: The use of next-generation sequencing technologies has aided in the discovery of novel gene loci in familial Parkinson's disease (PD), but the missing heritability of PD has not been resolved significantly. Third-generation sequencing technologies are needed to identify complex genomic rearrangements and new sequence variations. Additionally, studying ancestrally diverse populations and optimizing sequencing and analytic workflows for these populations are critical for exciting new discoveries in the field.

FRONTIERS IN GENETICS (2022)

Review Clinical Neurology

Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions

Artur Francisco Schumacher-Schuh, Andrei Bieger, Olaitan Okunoye, Kin Ying Mok, Shen-Yang Lim, Soraya Bardien, Azlina Ahmad-Annuar, Bruno Lopes Santos-Lobato, Matheus Zschornack Strelow, Mohamed Salama, Shilpa C. Rao, Yared Zenebe Zewde, Saiesha Dindayal, Jihan Azar, Lingappa Kukkle Prashanth, Roopa Rajan, Alastair J. Noyce, Njideka Okubadejo, Mie Rizig, Suzanne Lesage, Ignacio Fernandez Mata

Summary: This systematic review highlights the significant lack of population diversity in Parkinson's disease genetics research, emphasizing the urgent need for better representation. The Global Parkinson's Genetics Program (GP2) and similar initiatives aim to impact research in underrepresented populations, and the early metrics presented here can be used to measure progress in the field of PD genetics in the future.

MOVEMENT DISORDERS (2022)

Article Clinical Neurology

The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited

Cloe Domenighetti, Venceslas Douillard, Pierre-Emmanuel Sugier, Ashwin Ashok Kumar Sreelatha, Claudia Schulte, Sandeep Grover, Patrick May, Dheeraj R. Bobbili, Milena Radivojkov-Blagojevic, Peter Lichtner, Andrew B. Singleton, Dena G. Hernandez, Connor Edsall, Pierre-Antoine Gourraud, George D. Mellick, Alexander Zimprich, Walter Pirker, Ekaterina Rogaeva, Anthony E. Lang, Sulev Koks, Pille Taba, Suzanne Lesage, Alexis Brice, Jean-Christophe Corvol, Marie-Christine Chartier-Harlin, Eugenie Mutez, Kathrin Brockmann, Angela B. Deutschlander, Georges M. Hadjigeorgiou, Efthimos Dardiotis, Leonidas Stefanis, Athina Maria Simitsi, Enza Maria Valente, Simona Petrucci, Stefano Duga, Letizia Straniero, Anna Zecchinelli, Gianni Pezzoli, Laura Brighina, Carlo Ferrarese, Grazia Annesi, Andrea Quattrone, Monica Gagliardi, Hirotaka Matsuo, Akiyoshi Nakayama, Nobutaka Hattori, Kenya Nishioka, Sun Ju Chung, Yun Joong Kim, Pierre Kolber, Bart P. C. van de Warrenburg, Bastiaan R. Bloem, Jan Aasly, Mathias Toft, Lasse Pihlstrom, Leonor Correia Guedes, Joaquim J. Ferreira, Soraya Bardien, Jonathan Carr, Eduardo Tolosa, Mario Ezquerra, Pau Pastor, Monica Diez-Fairen, Karin Wirdefeldt, Nancy L. Pedersen, Caroline Ran, Andrea C. Belin, Andreas Puschmann, Emil Ygland Rodstrom, Carl E. Clarke, Karen E. Morrison, Manuela Tan, Dimitri KraincMD, Lena F. Burbulla, Matt J. Farrer, Rejko Kruger, Thomas Gasser, Manu Sharma, Nicolas Vince, Alexis Elbaz

Summary: This study conducted a large-scale independent replication of the interaction between HLA-DRB1 and smoking in Parkinson's disease. The valine at position 11 (V11) in HLA-DRB1 showed the strongest association with PD at the amino acid level. The results suggest an inverse association between genetically predicted smoking initiation and PD, particularly in individuals without the V11 variant. In silico predictions support this interaction pattern by showing the influence of V11 and smoking-induced modifications on binding affinity of alpha-synuclein.

MOVEMENT DISORDERS (2022)

Article Clinical Neurology

Increased blood-derived mitochondrial DNA copy number in African ancestry individuals with Parkinson?s disease

Amica Corda Muller-Nedebock, Surita Meldau, Carl Lombard, Shameemah Abrahams, Francois Hendrikus van der Westhuizen, Soraya Bardien

Summary: This study investigated whether blood mtDNA-CN levels of African ancestry PD cases would be altered compared to controls. The results showed significantly higher mtDNA-CN in the blood of PD cases.

PARKINSONISM & RELATED DISORDERS (2022)

Article Geriatrics & Gerontology

Mitochondrial DNA variation in Parkinson's disease: Analysis of out-of-place population variants as a risk factor

Amica C. Muller-Nedebock, Abigail L. Pfaff, Ilse S. Pienaar, Sulev Koks, Francois H. van der Westhuizen, Joanna L. Elson, Soraya Bardien

Summary: This study investigates the relationship between mitochondrial DNA (mtDNA) variation and Parkinson's disease (PD), focusing on out-of-place variation in African ancestry PD cases. The results show a significant association between out-of-place mtDNA variants and PD risk in African ancestry PD cases.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Article Clinical Neurology

PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability

Christina Fevga, Christelle Tesson, Ana Carreras Mascaro, Thomas Courtin, Riaan van Coller, Salma Sakka, Federico Ferraro, Nouha Farhat, Soraya Bardien, Mariem Damak, Jonathan Carr, Melanie Ferrien, Valerie Boumeester, Jasmijn Hundscheid, Nicola Grillenzoni, Irini A. Kessissoglou, Demy J. S. Kuipers, Marialuisa Quadri, Jean-Christophe Corvol, Chokri Mhiri, Bassem A. Hassan, Guido J. Breedveld, Suzanne Lesage, Wim Mandemakers, Alexis Brice, Vincenzo Bonifati

Summary: This study identified variants in the PTPA gene associated with early-onset parkinsonism and intellectual disability. These variants lead to impaired activation of the PP2A complex, resulting in neurodegeneration. The Drosophila model further confirmed this mechanism.

BRAIN (2022)

Article Clinical Neurology

Neurexin 2 p.G849D variant, implicated in Parkinson's disease, increases reactive oxygen species, and reduces cell viability and mitochondrial membrane potential in SH-SY5Y cells

Katelyn Cuttler, Dalene de Swardt, Lize Engelbrecht, Jurgen Kriel, Ruben Cloete, Soraya Bardien

Summary: The aim of this study was to investigate the potential role of the translated protein NRXN2 alpha and a specific mutant in Parkinson's disease (PD). Functional studies in an in vitro model showed that cells transfected with the mutant NRXN2 alpha plasmid exhibited decreased cell viability, decreased mitochondrial membrane potential, and increased reactive oxygen species production. These findings suggest that the p.G849D variant may be involved in neuronal death in PD.

JOURNAL OF NEURAL TRANSMISSION (2022)

Article Cell Biology

Black Lives Matter and Black Research Matters: the African Society of Human Genetics' call to halt racism in science

Ambroise Wonkam, Soraya Bardien, Rokhaya Ndiaye Diallo, Amadou Gaye, Mohamed Zahir Alimohamed, Siana Kya, Julie Makani, Guida Landoure, Leon Mutesa, Ghada El-Kamah, Amal Mohamed, Melanie Newport, Scott M. Williams, Michele Ramsay, Victoria Nembaware, Derek Applewhite

Summary: The African Society of Human Genetics aims to provide a platform for scientists in Africa to collaborate on human genetics and genomics research in order to address the public health burden posed by various diseases. They support the Black Lives Matter movement and advocate for an end to the exploitation of African people in genomic research.

MOLECULAR BIOLOGY OF THE CELL (2022)

Article Geriatrics & Gerontology

Proteomics analysis of the p.G849D variant in neurexin 2 alpha may reveal insight into Parkinson's disease pathobiology

Katelyn Cuttler, Suereta Fortuin, Amica Corda Muller-Nedebock, Mare Vlok, Ruben Cloete, Soraya Bardien

Summary: This study investigated the potential role of NRXN2 alpha in Parkinson's disease, finding that the wild-type NRXN2 alpha may be involved in pathways related to neurodegenerative disorders, while the mutant NRXN2 alpha may affect proteins involved in ribosomal functioning. These findings suggest that translation at the synapse, as well as biological processes related to the ribosome, transcription, and tRNA, may play an important role in the pathobiology of PD.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Article Pediatrics

A case for genomic medicine in South African paediatric patients with neuromuscular disease

Sharika V. Raga, Jo Madeleine Wilmshurst, Izelle Smuts, Surita Meldau, Soraya Bardien, Maryke Schoonen, Francois Hendrikus van der Westhuizen

Summary: Pediatric neuromuscular diseases are often overlooked and misdiagnosed in Africa, mainly due to socioeconomic barriers, a high burden of diseases, lack of expertise and genetic testing facilities. It is crucial to accurately diagnose these genetic diseases in order for affected children to be eligible for potential treatments. The introduction of a multi-centered research platform aims to address the limited knowledge and improve genetic diagnostic capacities in African populations.

FRONTIERS IN PEDIATRICS (2022)

Article Clinical Neurology

Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers

Pierre-Emmanuel Sugier, Elise A. Lucotte, Cloe Domenighetti, Matthew H. Law, Mark M. Iles, Kevin Brown, Christopher Amos, James D. McKay, Rayjean J. Hung, Mojgan Karimi, Delphine Bacq-Daian, Anne Boland-Auge, Robert Olaso, Jean-francois Deleuze, Fabienne Lesueur, Evgenia Ostroumova, Ausrele Kesminiene, Florent de Vathaire, Pascal Guenel, Ashwin Ashok Kumar Sreelatha, Claudia Schulte, Sandeep Grover, Patrick May, Dheeraj R. Bobbili, Milena Radivojkov-Blagojevic, Peter Lichtner, Andrew B. Singleton, Dena G. Hernandez, Connor Edsall, George D. Mellick, Alexander Zimprich, Walter Pirker, Ekaterina Rogaeva, Anthony E. Lang, Sulev Koks, Pille Taba, Suzanne Lesage, Alexis Brice, Jean-Christophe Corvol, Marie-Christine Chartier-Harlin, Eugenie Mutez, Kathrin Brockmann, Angela B. Deutschlaender, Georges M. Hadjigeorgiou, Efthimios Dardiotis, Leonidas Stefanis, Athina Maria Simitsi, Enza Maria Valente, Simona Petrucci, Letizia Straniero, Anna Zecchinelli, Gianni Pezzoli, Laura Brighina, Carlo Ferrarese, Grazia Annesi, Andrea Quattrone, Monica Gagliardi, Hirotaka Matsuo, Akiyoshi Nakayama, Nobutaka Hattori, Kenya Nishioka, Sun Ju Chung, Yun Joong Kim, Pierre Kolber, Bart P. C. van de Warrenburg, Bastiaan R. Bloem, Jan Aasly, Mathias Toft, Lasse Pihlstrom, Leonor Correia Guedes, Joaquim J. Ferreira, Soraya Bardien, Jonathan Carr, Eduardo Tolosa, Mario Ezquerra, Pau Pastor, Monica Diez-Fairen, Karin Wirdefeldt, Nancy Pedersen, Caroline Ran, Andrea C. Belin, Andreas Puschmann, Emil Ygland Roedstroem, Carl E. Clarke, Karen E. Morrison, Manuela Tan, Dimitri Krainc, Lena F. Burbulla, Matt J. Farrer, Rejko Kruger, Thomas Gasser, Manu Sharma, Therese Truong, Alexis Elbaz

Summary: By using genome-wide association studies, this study found that Parkinson's disease (PD) is genetically correlated with melanoma and prostate cancer, while it is inversely correlated with ovarian cancer. These findings suggest that pleiotropic genes contribute to the association between PD and specific cancers.

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

International Genetic Testing and Counseling Practices for Parkinson's Disease

Rachel Saunders-Pullman, Deborah Raymond, Roberto A. Ortega, Ali Shalash, Emilia Gatto, Mehri Salari, Maggie Markgraf, Roy N. Alcalay, Deborah Mascalzoni, Niccolo E. Mencacci, Vincenzo Bonifati, Marcelo Merello, Sun Ju Chung, Ivana Novakovic, Soraya Bardien, Gian Pal, Anne Hall, Nobutaka Hattori, Timothy Lynch, Avner Thaler, Carolyn M. Sue, Tatiana Foroud, Jennifer Verbrugge, Jeanine Schulze, Lola Cook, Karen Marder, Oksana Suchowersky, Christine Klein, Tatyana Simuni

Summary: This study aims to determine the international landscape of genetic testing in Parkinson's disease (PD) and provide information for future global recommendations. The survey found common barriers such as cost and access to genetic testing and counseling, as well as the need for education on genetic counseling. Region-dependent differences were most notable in Africa, while high-income countries showed heterogeneity, with European nations more likely to have genetic testing covered through insurance than Pan-American and Asian countries. In conclusion, improving education and access to genetic counseling and testing for PD worldwide is highly needed.

MOVEMENT DISORDERS (2023)

Review Clinical Neurology

Genetic Testing in Parkinson's Disease

Gian Pal, Lola Cook, Jeanine Schulze, Jennifer Verbrugge, Roy N. Alcalay, Marcelo Merello, Carolyn M. Sue, Soraya Bardien, Vincenzo Bonifati, Sun Ju Chung, Tatiana Foroud, Emilia Gatto, Anne Hall, Nobutaka Hattori, Tim Lynch, Karen Marder, Deborah Mascalzoni, Ivana Novakovic, Avner Thaler, Deborah Raymond, Mehri Salari, Ali Shalash, Oksana Suchowersky, Niccolo E. Mencacci, Tanya Simuni, Rachel Saunders-Pullman, Christine Klein

Summary: Testing for genetic markers in Parkinson's disease is increasingly common, and although there are no proven gene-targeted therapies, clinical trials are underway. However, there is a lack of consensus and guidelines in genetic testing practices, and various gaps and controversies need to be addressed, including appropriateness of testing, variation based on ethnicity, long-term outcomes, and resource needs.

MOVEMENT DISORDERS (2023)

Article Neurosciences

Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson's disease

Amica C. Mueller-Nedebock, Marieke C. J. Dekker, Matthew J. Farrer, Nobutaka Hattori, Shen-Yang Lim, George D. Mellick, Irena Rektorova, Mohamed Salama, Artur F. S. Schuh, A. Jon Stoessl, Carolyn M. Sue, Ai Huey Tan, Rene L. Vidal, Christine Klein, Soraya Bardien

Summary: The biological basis of Parkinson's disease, a neurodegenerative movement disorder, is still unclear despite being discovered over 200 years ago. This article summarizes the viewpoints of PD experts on the different theories regarding its pathobiology.

NPJ PARKINSONS DISEASE (2023)

No Data Available